Kessler Topaz Meltzer & Check, LLP Announces January 18, 2022 Deadline in Securities Fraud Class Action Lawsuit Filed Against of Owlet, Inc. Investors

CLICK HERE TO SUBMIT YOUR OWLET LOSSES

LIMIT FOR THE PLAINTIFF: January 18, 2022

LESSON: March 31, 2021 through October 4, 2021

CONTACT AN ATTORNEY TO DISCUSS YOUR RIGHTS:

James Maro, Esq. (484) 270-1453 or duty free (844) 887-9500 or email [email protected]

OWLETS ALLEGED MISCONDUCT

Owlet headquartered in Lehi, Utah, acts as a digital parenting platform focused on giving parents real-time data and insights. Products include: Owlet Monitor Duo, which captures a snapshot of baby’s well-being; Owlet Smart Sock, which tracks baby’s heart rate and oxygen while they sleep and gets notifications when baby needs checking; Owlet Cam, a smart HD video baby monitor; and Dream Lab, an online personalized sleep solution for infants.

on July 15, 2021, Sandbridge combined with the company Owlet Baby Care Inc. and the combined company was renamed Owlet. Then, on October 4, 2021, Owlet announced that it received a warning letter from the U.S. Food and Drug Administration (“FDA”). The FDA letter informed Owlet that its marketing of the Owlet Smart Sock in The United States “makes the smart sock a medical device that requires FDA pre-approval or approval, and so on [Owlet] has not obtained such clearance or approval in violation of federal, food, drug and cosmetic statutes Smart Sock for use in measuring blood oxygen saturation and pulse rate when such metrics are designed to identify desaturation and bradycardia using an alarm feature or diagnose to notify users that measurements are outside of preset values.

Following this news, Owlet’s share price fell $1.29, or 23% to close $4.19 per share October 4, 2021.

WHAT CAN I DO?

Owlet investors are allowed at the latest January 18, 2022, seek to be appointed lead plaintiff representative in the class action by Kessler Topaz Meltzer & Check, LLP or other counsel, or may elect to do nothing and remain an absentee class plaintiff. Kessler Topaz Meltzer & Check, LLP encourages Owlet investors who have suffered material losses to contact the company directly for more information.

CLICK HERE TO REGISTER FOR THE EVENT

Who can be a lead plaintiff?

A Lead Plaintiff is a representative party acting on behalf of all Group Members in conducting the litigation. The lead plaintiff is usually the investor or small group of investors who have the greatest financial interest and who are also appropriate and typical of the proposed class of investors. The lead plaintiff selects counsel to represent the lead plaintiff and class, and such attorneys, where permitted by the court, are principal or class counsel. Your ability to participate in a recovery will not be affected by the decision whether or not to serve as Lead Plaintiff.

ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP

Kessler Topaz Meltzer & Check, LLP is pursuing class action lawsuits in state and federal courts across the country and around the world. The company has earned a global reputation for excellence, recovering billions of dollars from victims of fraud and other corporate wrongdoing. All of our work is driven by a common goal: to protect investors, consumers, employees and others from fraud, abuse, wrongdoing and negligence on the part of companies and fiduciaries. At the end of the day, if the bad guys pay and you get your fortune back, we’re done. The action in this lawsuit was not filed by Kessler Topaz Meltzer & Check, LLP. Additional information about Kessler Topaz Meltzer & Check, LLP is available at www.ktmc.com.

CONTACT:
Kessler Topaz Meltzer & Check, LLP
James Maro, Jr., Esq.
280 König-von-Prussia-Strasse
Radnor, PA 19087
(844) 887-9500 (toll free)
[email protected]

SOURCE Kessler Topaz Meltzer & Check, LLP

Comments are closed.